INCA34176-357

Hematological neoplasms
Other indications (e.g. myeloproliferative diseases)
First-Line-Therapy (Metastatic Disease/Hematology)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft Versus-Host Disease
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft Versus-Host Disease